Global Transdermal Drug Delivery Systems Market, By Type (Transdermal Patches, Transdermal Semisolid

Published Date: | Report Code : HC1958476

X

The Transdermal Drug Delivery System Market is expected to promise high growth owing to the increasing demand for non-invasive treatment in recent years. Increasing demand from end-use industries including  Home Care Settings, Hospitals & Clinics is expected to drive the growth of the transdermal drug delivery system market. This market has witnessed a number of key developments by major companies including Hisamitsu Pharmaceutical, Mylan, UCB, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International with a focus on organic as well as inorganic growth strategies. Developing regions including the Asia Pacific and the Middle East have been among the high potential markets with high growth in some of the key economies. The transdermal drug delivery system is a form of a dosage that is applied directly to the skin to deliver the drug at a carful pace to the blood. This method of delivering drugs is the most systemic and indigenous process.

Segment Insights:

The transdermal drug delivery market is segmented based on the type, application, and end-users.

Based on the type the market is bifurcated into patches and semisolids. The patches segment for transdermal drug delivery is expected to grow. As these have various benefits such as improved bioavailability, reduced dosage frequency, reduction in the adverse effects and input termination by patch removal.

On the basis of the applications, the segmentation is Pain Management, Central Nervous System Disorders, Cardiovascular Diseases, Hormonal Applications, and Other Applications. The pain management segment has been leading and is anticipated to continue growing as there is a high incidence of chronic pains globally due to the poor posture of the people and various other occurrences. Also, the availability of transdermal drugs for the use of pain management has been growing steadily.

By the end-users, the segmentation is Home Care Settings, Hospitals & Clinics. There have been an increase in the geriatric population, a rise in incidences of self-administration of medication at homes, and a demand for cost-effective drug administration.

The North America region is the leading region in the market for transdermal drug delivery systems. This is due to the various factors such as an increase in the incidence of targeted diseases such as cardiovascular diseases, CNS disorders, and chronic pain. The numerous research activities being conducted relating to transdermal drug delivery systems have also been a major driving factor.

Key Factors Impacting Market Growth:

  • Increasing prevalence of chronic diseases

  • Growing demand for non-invasive treatment

Regional Analysis:

North America, Western Europe, and the Asia Pacific by region are estimated to dominate the transdermal drug delivery system market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for the transdermal drug delivery system market during the forecast period. The US, Germany, France, UK, Canada, and Spain have been some of the major markets in the region.

Asia Pacific is estimated to register one of the highest CAGR for the transdermal drug delivery system market during the forecast period. This region has witnessed strategic investments by global companies to cater to the growing demand in recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for the transdermal drug delivery system market in the region. Other regions including the Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets transdermal drug delivery systems during the forecast period.

Companies Covered: Hisamitsu Pharmaceutical, Mylan, UCB, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, and Purdue Pharma.

Market Segmentation:

By Type:

  • Transdermal Patches

  • Transdermal Semisolids

By Application:

  • Pain Management

  • Central Nervous System Disorders

  • Cardiovascular Diseases

  • Hormonal Applications

  • Other Applications

By End-Users:

  • Home Care Settings

  • Hospitals & Clinics

By Region:

  • North America

    • By Country (US, Canada, Mexico)

    • By Type

    • By Application

    • By End-Users

  • Western Europe

    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)

    • By Type

    • By Application

    • By End-Users

  • Eastern Europe

    • By Country (Russia, Turkey, Rest of Eastern Europe)

    • By Type

    • By Application

    • By End-Users

  • Asia Pacific

    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)

    • By Type

    • By Application

    • By End-Users

  • Middle East

    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)

    • By Type

    • By Application

    • By End-Users

  • Rest of the World

    • By Region (South America, Africa)

    • By Type

    • By Application

    • By End-Users

Reasons To Buy This Report:

  • Market size estimation of the global Transdermal Drug Delivery Systems Market on a regional and global basis

  • The unique research design for market size estimation and forecast

  • Profiling of major companies operating in the market with key developments

  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment

  • By Sub-segment

  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

 Regional Analysis

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy